Last updated on December 2018

Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated Unresectable Or Metastatic Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years


Brief description of study

A descriptive, prospective (partly retrospective), multisite, observational study conducted in France in adult patients treated for a well differentiated, unresectable or metastatic, pancreatic neuroendocrine tumor with disease progression.

Detailed Study Description

prospective and retrospective Analyses will be performed using SAS software

Clinical Study Identifier: NCT02264665

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

CHU de Strasbourg - Hopital de Hautepierre / Service de Medecine Interne et Nutrition
Strasbourg Cedex, France
1.53miles
  Connect »

Pfizer CT.gov Call Center

Clinique St.Anne
Strasbourg, France
1.96miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.